|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4439 | |
| A61P 5/26 | |||
| A61P 19/08 | |||
| A61P 21/06 | |||
| A61P 21/00 | |||
| C07D 209/94 | |||
| C07D 401/06 |
| (11) | Number of the document | 3191094 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15767383.1 |
| Date of filing the European patent application | 2015-09-08 | |
| (97) | Date of publication of the European application | 2017-07-19 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/048801 |
| Date | 2015-09-08 |
| (87) | Number | WO 2016/040234 |
| Date | 2016-03-17 |
| (30) | Number | Date | Country code |
| 201462049192 P | 2014-09-11 | US |
| (72) |
BENSON, Charles Thomas, US
|
| (73) |
Eli Lilly and Company,
940 S. East Street, Indianapolis, IN 46206-6288,
US
|
| (54) | TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMS |
| TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMS |